Solventum Corporation SOLV | NYSE

$67.15 $1.53 | 2.33%

Next Earnings: May 08, 2025

Company Overview:

Market Cap: $11.62B
PE Ratio: 24.33
52-Week Range: $47.16 - $85.92

1.1 Year Performance Metrics:

Total Return (with DRIP): -5.04% (-4.59% / yr)
Total Return (no DRIP): -5.04% (-4.59% / yr)
Share Price: -5.04%
SOLV Total Return
1Y 2Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

SOLV Earnings, Revenue, Cash & Debt, Shares Outstaning:

SOLV - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
SOLV - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
SOLV - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
SOLV - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
SOLV - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
SOLV - Cash & Debt
14-Day FREE Trial Get Full Access Now!
SOLV - Revenue
14-Day FREE Trial Get Full Access Now!
SOLV Revenue CAGR:1Y: -1.00%2Y: 1.71%5Y: 0.00%10Y: 0.00%
SOLV - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
SOLV EPS CAGR:1Y: -59.52%2Y: -69.10%5Y: 0.00%10Y: 0.00%
SOLV - Net Income
14-Day FREE Trial Get Full Access Now!
SOLV Net Income CAGR:1Y: -58.90%2Y: -68.74%5Y: 0.00%10Y: 0.00%
SOLV - EBITDA
14-Day FREE Trial Get Full Access Now!
SOLV EBITDA CAGR:1Y: -72.19%2Y: -49.49%5Y: 0.00%10Y: 0.00%
SOLV - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
SOLV Free Cash Flow CAGR:1Y: -79.96%2Y: -49.73%5Y: 0.00%10Y: 0.00%
SOLV - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
SOLV Free Cash Flow / Share CAGR:1Y: -80.06%2Y: -49.86%5Y: 0.00%10Y: 0.00%
SOLV - Gross Profit
14-Day FREE Trial Get Full Access Now!
SOLV Gross Profit CAGR:1Y: 0.36%2Y: 0.45%5Y: 0.00%10Y: 0.00%
SOLV - Expenses
14-Day FREE Trial Get Full Access Now!
SOLV Expenses CAGR:1Y: 44.32%2Y: 24.45%5Y: 0.00%10Y: 0.00%
SOLV - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
SOLV Shares Outstanding CAGR:1Y: 1.18%2Y: 0.59%5Y: 0.00%10Y: 0.00%
SOLV - Share Buybacks
14-Day FREE Trial Get Full Access Now!
SOLV Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
SOLV - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
SOLV Stock-Based Comp CAGR:1Y: -100.00%2Y: -100.00%5Y: 0.00%10Y: 0.00%
SOLV - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
SOLV Revenue CAGR:1Y: -1.00%2Y: 1.71%5Y: 0.00%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

SOLV - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
SOLV Actual Revenue CAGR:1Y: -1.00%2Y: 1.71%5Y: 0.00%10Y: 0.00%
SOLV - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
SOLV Actual EPS CAGR:1Y: -59.52%2Y: -69.10%5Y: 0.00%10Y: 0.00%
SOLV - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
SOLV Actual Net Income CAGR:1Y: -58.90%2Y: -68.74%5Y: 0.00%10Y: 0.00%
SOLV - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
SOLV Actual EBITDA CAGR:1Y: -72.19%2Y: -49.49%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

SOLV - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
SOLV Net Profit Margin CAGR:1Y: -58.33%2Y: -69.23%5Y: 0.00%10Y: 0.00%
SOLV - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
SOLV Gross Profit Margin CAGR:1Y: 1.37%2Y: -1.24%5Y: 0.00%10Y: 0.00%
SOLV - Price to Earnings
14-Day FREE Trial Get Full Access Now!
SOLV - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
SOLV - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
SOLV - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

Projected Future Returns & Dividends for SOLV

Based on past 1.1-year performance, here are SOLV growth metrics:

Share price CAGR of -4.59%
Dividend CAGR of +0%

Using SOLV CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

SOLV (DRIP)SOLV - No DRIP
Current Price$65.62$65.62
Start Shares152.39152.39
Start Value$10,000$10,000
  
After 10 years:
Final Share Count152.39152.39
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$43.00$65.62
Total Dividends$0$0
Final Value$6,552$10,000

Estimated Future Value + Dividends - SOLV

NOTE: Above numbers are our estimate based on SOLV's Dividend and Price CAGR over past 1.1 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Solventum Corporation (SOLV) had its IPO on , and is trader on NYSE stock exchange.

SOLV website: https://www.solventum.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial